NIH

arm with IV line
June 4, 2015

Study identifies C. diff toxin receptor, suggests new treatment approaches

Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

By Leigh MacMillan
June 4, 2015

Garrison named to NIH diversity working group

Nanibaa’ Garrison, Ph.D., assistant professor of Pediatrics and Anthropology, has been appointed to serve on the Working Group on Diversity, which is an arm of the Advisory Committee to the Director (ACD) of the National Institutes of Health (NIH).

By Paul Govern
June 4, 2015

NIH director’s Discovery Lecture covers biomedical research landscape

Last week in Langford Auditorium, Francis Collins, M.D., Ph.D., director of the National Institutes of Health (NIH), delivered what he referred to as a “romp through an awful lot of the landscape of biomedical research.”

By Paul Govern
June 4, 2015

Precision medicine efforts highlighted at NIH workshop

Affirmation of Vanderbilt University Medical Center’s high profile in precision medicine came last week when a new working group convened by the National Institutes of Health (NIH) visited Vanderbilt for a two-day public workshop devoted to planning a key component of the federal Precision Medicine Initiative announced earlier this year by President Obama.

By Paul Govern
microscope
May 28, 2015

Research at U.S. academic medical centers faces threats to sustainable support

Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever.

By Bill Snyder
May 21, 2015

NIH director set for Discovery Lecture

National Institutes of Health Director Francis Collins, M.D., Ph.D., will deliver a special Discovery Lecture at Vanderbilt University Medical Center next Thursday, May 28.

By Bill Snyder
May 20, 2015

Preventing early pregnancy complications

The enzyme alkaline phosphatase may provide a new therapeutic option for women at high risk of pregnancy complications due to bacterial toxin exposure.
By Leigh MacMillan
May 15, 2015

VU lands $9 million NIH grant to design better flu vaccines

Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
By Bill Snyder
May 15, 2015

Boosting cell-based heart repair

A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells.
By Leigh MacMillan
May 14, 2015

Precision medicine focus of NIH workshop

On May 28-29 at Vanderbilt, the Precision Medicine Initiative Working Group of the Advisory Committee to the Director of the National Institutes of Health (NIH) will hold a public workshop devoted to research cohorts and electronic health records.
By Paul Govern
May 14, 2015

Insights on lysosomal storage diseases

A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features.
By Leigh MacMillan
May 6, 2015

Neurofibromin fine-tunes bone growth

The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered.
By Leigh MacMillan
May 1, 2015

New player in neuronal communication

Vanderbilt researchers have discovered a novel mechanism for the development of dendritic spines – sites of nerve cell communication.
By Leigh MacMillan
1 … 63 64 65 66 67 … 101